文献速递免疫规划传染病防控与疫情报告

十价肺炎球菌结合疫苗接种对芬兰儿童侵袭性肺炎球菌疾病的长期影响

Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
PubMed 文献 · Vaccine · 2018-03-08

本研究基于芬兰国家人群监测数据,评估十价肺炎球菌结合疫苗(PCV10)纳入国家疫苗接种计划六年后对疫苗适龄儿童及未接种年长儿童侵袭性肺炎球菌疾病(IPD)的长期影响。结果显示,疫苗适龄儿童全因IPD发病率下降79%(95%CI 74-83%),6A型IPD显著下降,19A型下降不显著且研究末期在年长适龄儿童中上升;未接种年长儿童全因IPD下降33%(95%CI 8-52%),对6A和19A型无影响。结论认为PCV10对疫苗适龄儿童IPD影响显著,对6A型有持久直接交叉保护,对19A型六年未见净减少,未接种儿童中间接影响持续。

要点

  • 疫苗适龄儿童全因IPD发病率下降79%(95%CI 74-83%)。
  • 6A型IPD显著下降,19A型下降不显著且研究末期在年长适龄儿童中上升。
  • 未接种年长儿童全因IPD下降33%(95%CI 8-52%),对6A和19A型无影响。

核心结论

  • PCV10对疫苗适龄儿童IPD影响显著,疫苗型疾病大幅减少,未见其他血清群明显替代。
  • 数据提示PCV10对6A型IPD产生持久直接交叉保护;对19A型,国家疫苗接种计划引入六年后疫苗适龄队列未见净减少。
  • 未接种儿童中间接影响持续。

研究设计与样本

  • 基于国家人群监测的IPD数据,疫苗适龄队列为2010年6月或之后出生儿童,从3月龄随访至2016年底。
  • 间接效应队列为年长PCV10不适龄儿童,2012年至2016年随访。
  • IPD发病率与疫苗接种计划引入前季节和年龄匹配的参考队列比较。

主要发现

  • 疫苗适龄儿童中,全因IPD发病率下降79%(95%CI 74-83%)。
  • 6A型IPD发病率下降有统计学意义;19A型下降不显著,且研究末期年长疫苗适龄儿童中19A发病率上升。
  • 非PCV10相关血清型增加不显著。
  • 未接种年长儿童中,全因IPD发病率较参考队列下降33%(95%CI 8-52%),对6A或19A型IPD无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Programme (NVP) in September 2010. The impact of PCV10 vaccination against invasive pneumococcal disease (IPD) in vaccine-eligible children has been high. We evaluated the long-term impact of PCV10 vaccination against IPD in vaccine-eligible and older, unvaccinated children six years after PCV10 introduction with a special focus on cross-protection against PCV10-related serotypes (serotypes in the same serogroups as the PCV10 types). METHODS: We used data on IPD from the national, population-based surveillance. A target cohort of vaccine-eligible children (born June 2010 or later) was followed from 3 months of age until the end of 2016. For the indirect effect, another cohort of older PCV10-ineligible children was followed from 2012 through 2016. IPD rates were compared with those of season- and age-matched reference cohorts before NVP introduction. RESULTS: Among vaccine-eligible children, the incidence of all IPD decreased by 79% (95% CI 74-83%). There was a statistically significant reduction in the incidence of 6A IPD, but for 19A, the reduction was non-significant and the incidence of 19A increased towards the end of the study period in the older vaccine-eligible children. The increase in non-PCV10 related serotypes was non-significant. In the unvaccinated older children, the incidence of all IPD decreased by 33% (95% CI 8-52%) compared to the reference cohort, and there was no impact on serotype 6A or 19A IPD. CONCLUSION: Overall, the impact of PCV10 vaccination on IPD was high in vaccine-eligible children, with a major reduction in vaccine-type disease, and without notable replacement by other serotype groups. Our data suggest that PCV10 results in long-lasting direct cross-protection against 6A IPD. For 19A, no net reduction was observed six years after NVP introduction in the vaccine-eligible cohort. The indirect impact on IPD in unvaccinated children sustained.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rinta-Kokko H, Palmu AA, Auranen K, et al. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland. Vaccine. 2018. PMID: 29526371. doi:10.1016/j.vaccine.2018.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。